Identifying difficult-to-treat depression: differential diagnosis, subtypes, and comorbidities

The Journal of Clinical Psychiatry
Bradley N Gaynes

Abstract

Treatment-resistant depression (TRD) is a common clinical presentation responsible for much of the burden of major depressive disorder worldwide. For this reason, TRD requires aggressive identification and management. Although several models have been proposed to describe TRD, consensus is still needed on the criteria (ie, dose, duration, compliance, number of trials required) used to define treatment response and resistance. When diagnosing patients with depression, clinicians should identify risk factors associated with treatment resistance, including clinical subtypes of depression and medical or psychiatric comorbidities that could affect the course of treatment. When evaluating a patient who has not responded to a first course of antidepressant treatment, the clinician should verify the primary diagnosis and ensure that the patient has adhered to a treatment regimen that was of adequate dose and duration.

Citations

Feb 7, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Mu-Hong Chen, Shih-Jen Tsai
Apr 28, 2010·Expert Review of Neurotherapeutics·William V Bobo, Richard C Shelton
Jan 7, 2015·Pharmacology & Therapeutics·Sonali ReisingerDaniela D Pollak
Dec 6, 2011·European Psychiatry : the Journal of the Association of European Psychiatrists·J L R Martin, E Martín-Sánchez
Mar 1, 2011·Asian Journal of Psychiatry·Meera NarasimhanAnna-Mobley Johnson
Jul 31, 2012·Journal of Affective Disorders·Martijn S van NoordenErik J Giltay
May 24, 2016·The Lancet. Psychiatry·Robin L Carhart-HarrisDavid J Nutt
Apr 27, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robin L Carhart-Harris, Guy M Goodwin
Nov 19, 2011·Journal of Pharmacy Practice·Monica Mathys, Brian G Mitchell
Oct 3, 2017·Expert Opinion on Therapeutic Patents·Tâmara Coimbra DinizJackson Roberto Guedes da Silva Almeida
Jun 20, 2020·Journal of Managed Care & Specialty Pharmacy·Maryia ZhdanavaCraig Nelson
Oct 21, 2014·European Archives of Psychiatry and Clinical Neuroscience·Roberto Goya-MaldonadoOliver Gruber
Oct 30, 2018·Frontiers in Psychology·Taylor Lyons, Robin Lester Carhart-Harris

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.